User:Jesse D. Kirkpatrick
- Jesse D. Kirkpatrick
- Address 1
- Address 2
- City, State, Country etc.
- Email me through OpenWetWare
- 2015, Bachelor of Science in Biological Engineering, Massachusetts Institute of Technology
Gastrointestinal/Liver Diseases- Studied Inflammatory Bowel Disease during the summer of 2012 at the Abreu Lab in Miami, FL. Currently studying Primary Sclerosing Cholangitis with the Freedman Lab at Beth Israel-Deaconess Medical Center in Boston, MA.
Registration/Questionnaire: 20.109 Spring 2013
Year of Graduation
lydonem at mit dot edu
Preferred OH Time
evenings during the week and Sundays during morning/afternoon
Potentially Relevant Background
Have you already taken MIT's BioSafety training? yes
|Have you taken/are you taking...||Answer yes/no/when|
|7.05/5.07 (Biochemistry)||taking now|
|7.06 (Cell Biology)||fall 2013|
|7.03 (Genetics)||taking now|
|5.310 (General Chemistry Lab)||not taking|
|Do you have experience with...||Answer yes/no/type|
|Cell culture (microbial/mammalian/yeast?)||yes, mammalian|
|Molecular biology (electrophoresis, PCR, etc)||protein assays|
Please briefly describe any previous laboratory experience
January 2013 - Present: Freedman Lab at Beth Israel-Deaconess Medical Center. Studying role of immunological signaling in cftr -/- cholangiocytes to understand CFTR's role in Primary Sclerosing Cholangitis
June - August 2012: Abreu Lab at University of Miami Hospital. Studied role of toll-like receptor 4 signaling in intestinal epithelial cells to investigate effects on inflammation. Studied high fat diet in the presence of colitis in an Ulcerative Colitis mouse model.
December - May 2012: Vacanti Lab at Massachusetts General Hospital. Engineered a biomimetic liver scaffold and ran in vitro tests.
Commitment to academic integrity
After you print out this page, please sign your name under to the following statement to indicate your agreement:
I have read and understood the 20.109 statement on collaboration and integrity.*Jesse D. Kirkpatrick 02:08, 12 February 2013 (EST):